Second-generation drug-eluting stents in the elderly patients with acute coronary syndrome: the in-hospital and 12-month follow-up of the all-comer registry

被引:2
|
作者
Wanha, Wojciech [1 ]
Kawecki, Damian [2 ]
Roleder, Tomasz [1 ]
Morawiec, Beata [2 ]
Gladysz, Sylwia [1 ]
Kowalowka, Adam [3 ]
Jadczyk, Tomasz [1 ]
Adamus, Barbara [4 ]
Pawlowski, Tomasz [1 ]
Smolka, Grzegorz [1 ]
Kazmierski, Maciej [1 ]
Ochala, Andrzej [1 ]
Nowalany-Kozielska, Ewa [2 ]
Wojakowski, Wojciech [1 ]
机构
[1] Med Univ Silesia, Div Cardiol 3, Katowice, Poland
[2] Med Univ Silesia, Div Cardiol 2, Zabrze, Poland
[3] Med Univ Silesia, Div Cardiothorac Surg, Katowice, Poland
[4] Specialist Hosp, Div Cardiol, Wilkowice, Poland
关键词
Percutaneous coronary intervention; Drug-eluting stents; Elderly patients; ELEVATION MYOCARDIAL-INFARCTION; ANGIOPLASTY REGISTRY; CLINICAL-OUTCOMES; AGE; INTERVENTION; IMPACT; TRIALS; REVASCULARIZATION; ANTIPLATELET; ANGIOGRAPHY;
D O I
10.1007/s40520-016-0649-8
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Katowice-Zabrze registry provides data that can be used to evaluate clinical outcomes of percutaneous coronary interventions in elderly patients (>= 70 y/o) treated with either first- (DES-I) or second-generation (DES-II) drug-eluting stents (DES). Methods The registry consisted of data from 1916 patients treated with coronary interventions using either DES-I or DES-II stents. For our study, we defined patients >= 70 years of age as elderly. We evaluated any major adverse cardiac and cerebral events (MACCE) at 12-month follow-up. Results Coronary angiography revealed a higher incidence of multivessel coronary artery disease in this elderly patient population. There were no differences in acute and subacute stent thrombosis (0.4 vs. 0.6%, p = 0.760; 0.4 vs. 0.4%; p = 0.712). Elderly patients experienced more in-hospital bleeding complications requiring blood transfusion (2.0 vs. 0.9%; p = 0.003). Resuscitated cardiac arrests (2.0 vs. 0.9%; p = 0.084) were observed more often in this elderly patients during hospitalization. The composite in-hospital MACCE rates did not differ statistically between both groups (1.4 vs. 1.1%; p = 0.567). Data from a twelve-month follow-up disclosed that mortality was higher (7.1 vs. 1.8%; p < 0.001) in the elderly, with no difference in TVR (7.2 vs. 9.9%, p = 0.075), MI (6.0 vs. 4.8%, p = 0.300), stroke (0.8 vs. 0.6%, p = 0.600) and composite MACCE (15.0 vs. 13.4%, p = 0.324). The age of 70 years or over was an independent predictor of death [HR = 2.55 (95% CI 1.49-4.37); p < 0.001]. The use of DES-II reduced the risk of MI [HR = 0.40 (95% CI 0.19-0.82); p = 0.012] in the elderly. Conclusion This elderly patient population had an increased risk of in-hospital bleeding complications requiring blood transfusion and a higher risk of death at 12-month follow-up. The use of new-generation DES reduced the risk of MI in the elderly population.
引用
收藏
页码:885 / 893
页数:9
相关论文
共 50 条
  • [1] Second-generation drug-eluting stents in the elderly patients with acute coronary syndrome: the in-hospital and 12-month follow-up of the all-comer registry
    Wojciech Wańha
    Damian Kawecki
    Tomasz Roleder
    Beata Morawiec
    Sylwia Gładysz
    Adam Kowalówka
    Tomasz Jadczyk
    Barbara Adamus
    Tomasz Pawłowski
    Grzegorz Smolka
    Maciej Kaźmierski
    Andrzej Ochała
    Ewa Nowalany-Kozielska
    Wojciech Wojakowski
    Aging Clinical and Experimental Research, 2017, 29 : 885 - 893
  • [2] Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry)
    Kawecki, Damian
    Morawiec, Beata
    Dola, Janusz
    Wanha, Wojciech
    Smolka, Grzegorz
    Pluta, Aleksandra
    Marcinkiewicz, Kamil
    Ochala, Andrzej
    Nowalany-Kozielska, Ewa
    Wojakowski, Wojciech
    MEDICAL SCIENCE MONITOR, 2015, 21
  • [3] REabsorbable vs. DUrable Polymer Drug-Eluting Stents in All-Comer PatiEnts: the REDUCE registry
    Piccirillo, Francesco
    Caiazzo, Gianluca
    Miglionico, Marco
    Nusca, Annunziata
    Melfi, Rosetta
    Gallo, Paolo
    Ricottini, Elisabetta
    De Michele, Mario
    Golino, Luca
    Manganiello, Vincenzo
    Fattore, Luciano
    Mangiacapra, Fabio
    Di Sciascio, Germano
    CORONARY ARTERY DISEASE, 2021, 32 (04) : 281 - 287
  • [4] Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry
    Baber, Usman
    Giustino, Gennaro
    Wang, Tracy
    Grines, Cindy
    McCoy, Lisa A.
    Saha-Chaudhuri, Paramita
    Best, Patricia
    Skelding, Kimberly A.
    Ortega, Rebecca
    Chieffo, Alaide
    Mehilli, Julinda
    Tcheng, James
    Mehran, Roxana
    CORONARY ARTERY DISEASE, 2016, 27 (06) : 442 - 448
  • [5] Safety and efficacy of a second-generation coronary sirolimus-eluting stent with biodegradable polymers in daily clinical practice: a 12-month follow-up of the ALEX registry
    Hawranek, Michal
    Desperak, Piotr
    Cislak, Aneta
    Gasior, Pawel
    Gierlotka, Marek
    Was, Tomasz
    Chodor, Piotr
    Kowalczyk, Jacek
    Lekston, Andrzej
    Gasior, Mariusz
    CORONARY ARTERY DISEASE, 2016, 27 (02) : 89 - 94
  • [6] First-Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry)
    Kawecki, Damian
    Morawiec, Beata
    Dola, Janusz
    Wanha, Wojciech
    Smolka, Grzegorz
    Pluta, Aleksandra
    Marcinkiewicz, Kamil
    Ochala, Andrzej
    Nowalany-Kozielska, Ewa
    Wojakowski, Wojciech
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2016, 106 (05) : 373 - 381
  • [7] Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome
    Ma, Yuan-Liang
    Tang, Xiao-Fang
    Yao, Yi
    Xu, Na
    Song, Ying
    Jiang, Ping
    Xu, Jing-Jing
    Wang, Huan-Huan
    Jiang, Lin
    Liu, Ru
    Zhao, Xue-Yan
    Chen, Jue
    Gao, Zhan
    Qiao, Shu-Bin
    Yang, Yue-Jin
    Gao, Run-Lin
    Xu, Ba
    Yuan, Jin-Qing
    CHINESE MEDICAL JOURNAL, 2018, 131 (12) : 1397 - 1405
  • [8] Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome
    Ma Yuan-Liang
    Tang Xiao-Fang
    Yao Yi
    Xu Na
    Song Ying
    Jiang Ping
    Xu Jing-Jing
    Wang Huan-Huan
    Jiang Lin
    Liu Ru
    Zhao Xue-Yan
    Chen Jue
    Gao Zhan
    Qiao Shu-Bin
    Yang Yue-Jin
    Gao Run-Lin
    Xu Bo
    Yuan Jin-Qing
    中华医学杂志英文版, 2018, 131 (12) : 1397 - 1405
  • [9] Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents
    Li, Xiao-tao
    Sun, Hao
    Zhang, Da-peng
    Xu, Li
    Ni, Zhu-hua
    Xia, Kun
    Liu, Yu
    Chi, Yong-hui
    He, Ji-fang
    Li, Wei-ming
    Wang, Hong-shi
    Wang, Le-feng
    Yang, Xin-chun
    CORONARY ARTERY DISEASE, 2014, 25 (05) : 405 - 411
  • [10] Comparison of 9-Month Angiographic Follow-Up and Long-Term Clinical Outcomes of Biodegradable Polymer Drug-Eluting Stents and Second-Generation Durable Polymer Drug-Eluting Stents in Patients Undergoing Single Coronary Artery Stenting
    Tsai, Ming-Lung
    Hsieh, Ming-Jer
    Chen, Chun-Chi
    Chang, Shang-Hung
    Wang, Chao-Yung
    Chen, Dong-Yi
    Yang, Chia-Hung
    Yeh, Jih-Kai
    Ho, Ming-Yun
    Hsieh, I-Chang
    ACTA CARDIOLOGICA SINICA, 2020, 36 (02) : 97 - 104